Dudediligence.

Neurocrine Biosciences, Inc

NBIXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 288-KOfficer or director change5.02
  2. Jul 318-K/AFinancial statements and exhibits (amended)9.01
  3. Jul 3110-QQuarterly report
  4. Jul 308-KResults of operations2.029.01
  5. May 288-KOfficer or director change and shareholder vote5.025.07
  6. May 188-KMaterial agreement and acquisition or sale of assets completed1.012.012.037.019.01
  7. May 510-QQuarterly report
  8. May 58-KResults of operations2.029.01
  9. Apr 68-KMaterial agreement1.019.01
  10. Feb 1110-KAnnual report
  11. Feb 118-KResults of operations2.029.01
  12. Nov 24, 20258-KOfficer or director change5.029.01
  13. Oct 28, 202510-QQuarterly report
  14. Oct 28, 20258-KResults of operations2.029.01
  15. Jul 30, 202510-QQuarterly report
  16. Jul 30, 20258-KResults of operations2.029.01
  17. May 30, 20258-KOfficer or director change5.029.01
  18. May 22, 20258-KOfficer or director change and shareholder vote5.025.07
  19. May 5, 202510-QQuarterly report
  20. May 5, 20258-KResults of operations2.029.01
  21. Apr 4, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01